ADMA BIOLOGICS, INC. (ADMA) Total liabilities 2016–2025
ADMA BIOLOGICS, INC. (ADMA) total liabilities at each fiscal year-end, per SEC filings.
$146.9MFY2025 · since FY2016: $28.1M → $146.9M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $146.9M | +5.2% |
| FY2024 | $139.7M | -28.0% |
| FY2023 | $194.0M | -1.3% |
| FY2022 | $196.5M | +45.5% |
| FY2021 | $135.1M | +13.1% |
| FY2020 | $119.4M | +18.4% |
| FY2019 | $100.9M | +46.0% |
| FY2018 | $69.1M | +2.1% |
| FY2017 | $67.7M | +140.5% |
| FY2016 | $28.1M | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice